1Rosenberg SA, Lotze MT, Muul LM, et al. A progress report on the treatment of 157 patients in advanced cancer using lymphokin-2 alone, N Engl J Med,1987,316(15):889.
2Bosenberg SA, Lotze MT, Muul LM, et al. Observation on the systemic administration of autologus lympholin-activated killer cells and recombinate interleukin-2 to patients with metastatic cancer. N Engl J Med,1985,313(15):14865.
